Suppr超能文献

靶向铱(III)光敏剂用于光动力疗法的设计研究进展。

Recent Advances in the Design of Targeted Iridium(III) Photosensitizers for Photodynamic Therapy.

机构信息

Department of Chemistry, University of Warwick, Gibbet Hill, Coventry, CV4 7AL, UK.

出版信息

Chembiochem. 2018 Aug 6;19(15):1574-1589. doi: 10.1002/cbic.201800182. Epub 2018 Jul 18.

Abstract

Photodynamic therapy (PDT) is a noninvasive treatment for certain types of cancer, bacterial, fungal and viral infections, and skin diseases. In recent years, adaptation of this treatment so as to achieve more specific targeted cancer therapy in particular has attracted significant attention. We focus herein on the design of novel iridium-based photosensitizers (PSs) with tunable photophysical and photobiological properties as efficient PDT agents. We highlight the ability of some Ir photosensitizers to target specific cellular components, including their activation by one- and two-photon irradiation.

摘要

光动力疗法(PDT)是一种针对某些类型的癌症、细菌、真菌和病毒感染以及皮肤病的非侵入性治疗方法。近年来,这种治疗方法的改进,特别是针对特定癌症的更具针对性的治疗方法,引起了人们的极大关注。我们在此专注于设计具有可调谐光物理和光生物学性质的新型基于铱的光敏剂(PS),将其作为有效的 PDT 试剂。我们强调了一些 Ir 光敏剂靶向特定细胞成分的能力,包括它们通过单光子和双光子辐射的激活。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验